Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company expects growth for both its lead transcatheter aortic valve replacement (TAVR) business and the company to fall below its full-year estimates, with a mid-year indication expansion for TAVR providing a critical boost in the back half of 2025. Read More
Biotronik Neuro’s Prospera spinal cord stimulation system achieved more than 50% pain reduction for 86% of patients with back pain and 89% of patients with leg pain over two years, according to new study results. Read More
The European Commission’s proposal for an AI-specific liability law seemed destined to pile onto existing EU liability law, but the commission reported it will pull the legislative proposal dubbed the AI Liability Directive. Read More
The U.S. Preventive Services Task Force updated a 2018 series of recommendations for screening for osteoporosis, but the update has its detractors. Read More
A recent patent application from Laleh Rad, associate professor of Biomedical Engineering and Radiology at Northwestern University, describes the use of machine learning for real-time risk assessment of magnetic resonance imaging in patients with conductive implants for whom tissue heating from radiofrequency excitation fields remains a major concern. Read More
With the first company in the world announcing more than $1 billion in annual revenue from pulsed field ablation on Feb. 5, Clarivate plc and BioWorld MedTech’s latest report provides well-timed insight into the stunning growth and bright future of this new medical technology for the treatment of atrial fibrillation. Read More
Med-tech firms raising money in public or private financings, including: Diagnostyka, Germitec, Microbot Medical, Predictmedix AI, Sera Prognostics. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Caris Life Sciences, Cognito Therapeutics. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Access Vascular, Arteraai, Grail, Mediwound, Quest, Recon Supply, Tempus. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Neuvotion. Read More
